CytRx Corp. buy melinda
Start price
13.06.17
/
50%
€3.13
Target price
22.06.17
€3.79
Performance (%)
21.80%
End price
22.06.17
€3.82
Summary
This prediction ended on 22.06.17 with a price of €3.82. The prediction had a final performance of 21.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
